Molecule of the month. Ruboxistaurin mesilate hydrate.
D017322:Clinical Trials, Phase II as Topic; D048909:Diabetes Complications; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000209:etiology; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000209:etiology; D003930:Diabetic Retinopathy / Q000188:drug therapy* / Q000209:etiology; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008301:Maleimides / Q000627:therapeutic use*
D004791:Enzyme Inhibitors; D007211:Indoles; D008301:Maleimides; C099154:ruboxistaurin